Concepedia

Daniel Jaller

DJ

3

Publications

377

Citations

3

H-Index

2008

Active since

Affiliations

Lankenau Institute for Medical Research(Current)

Thomas Jefferson University

Sidney Kimmel Cancer Center

Daniel Jaller is an author at Lankenau Institute for Medical Research specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2008–2010

3

Publications

3

Indoleamine 2,3-Dioxygenase Is the Anticancer Target for a Novel Series of Potent Naphthoquinone-Based Inhibitors

Sanjeev Kumar, William P. Malachowski, James B. DuHadaway et al. · Journal of Medicinal Chemistry · 2008 · 165 citations · Full text

Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-Dioxygenase

Sanjeev Kumar, Daniel Jaller, Bhumika Patel et al. · Journal of Medicinal Chemistry · 2008 · 149 citations · Full text

, , +13

Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth with Ethyl Pyruvate

Alexander J. Muller, James B. DuHadaway, Daniel Jaller et al. · Cancer Research · 2010 · 63 citations · Full text

, , +19

Rows per page

1–3 of 3